首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:European journal of nuclear medicine and molecular imaging

缩写:EUR J NUCL MED MOL I

ISSN:1619-7070

e-ISSN:1619-7089

IF/分区:7.6/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引6536
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Kenichi Nakajima,Takahiro Doi,Tomoaki Nakata et al. Kenichi Nakajima et al.
Purpose: Differentiating heart failure-related death (HFD) from arrhythmic events (ArEs) is clinically important for patients with chronic heart failure (CHF), as they have distinct mechanisms and therapeutic strategies. ...
Dimitrios Priftakis,Fadilah Aziz,Noora Bin Essa et al. Dimitrios Priftakis et al.
Purpose: To compare the performance of a multidisciplinary team (MDT) with the proposed standardized PROMISE classification system for indeterminate bone uptake on staging PSMA PET. ...
Dilara Denizmen Zorba,Duygu Has Simsek,Yasemin Sanli et al. Dilara Denizmen Zorba et al.
Purpose: Chronic bone and soft tissue infections pose a diagnostic challenge, as conventional imaging techniques often show limited sensitivity and specificity. Given that CXCR4 chemokine receptors are expressed on lympho...
Sajjad Sadeghpour,Atena Aghaee,Saba Sadeghpour et al. Sajjad Sadeghpour et al.
Objectives: In this systematic review, we evaluated the accuracy of baseline fibroblast activation protein inhibitor (FAPI)-based PET scans for predicting overall survival (OS), progression-free survival (PFS), and tumor ...
Juyeon Ko,Gayeong Son,Ha Eun Seo et al. Juyeon Ko et al.
Purpose: Impaired glymphatic function is considered an important characteristic of cognitive decline, but the role of tau pathology as a mediator remains unclear. This study investigated whether tau burden mediates the as...
Wolfram A Bosbach,Radi Saiyed Alsheikh,Nasir Gözlügöl et al. Wolfram A Bosbach et al.
Introduction: We investigated whether prompt changes in prostate-specific-antigen (PSA) levels within two days after the first cycle of prostate-specific-membrane-antigen radioligand therapy (PSMA-RLT) with [177Lu]Lu-PSMA...